Feedkast

Recap: A Review of Multiple Myeloma Trials That Impact the Standard of CareA panel of experts provides a discussion on treatments for newly diagnosed transplant-eligible and transplant-ineligible relapsed multiple myeloma, and how recent clinical trial data presented at ASH 2021 can be applied to clinical practice.A panel of experts provides a discussion on treatments for newly diagnosed…

Read the full article here

Related Articles